All Publications

  1. Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, Feng S. Reply (to LTE HEP-17-2332). Hepatology. 2018 Jan 29. View in PubMed
  2. Giard JM, Mehta N, Dodge JL, Roberts JP, Yao FY. Alpha-fetoprotein Slope >7.5 ng/ml/month Predicts Micro-vascular Invasion and Tumor Recurrence after Liver Transplantation for Hepatocellular Carcinoma. Transplantation. 2018 Jan 17. View in PubMed
  3. Mehta N, Guy J, Frenette CT, Dodge JL, Osorio RW, Minteer WB, Roberts JP, Yao FY. Excellent Outcomes of Liver Transplantation Following Down-Staging of Hepatocellular Carcinoma to Within Milan Criteria: A Multicenter Study. Clin Gastroenterol Hepatol. 2017 Nov 23. View in PubMed
  4. Shaw BI, Burdine LJ, Braun HJ, Ascher NL, Roberts JP. A Formula to Calculate Standard Liver Volume Using Thoracoabdominal Circumference. Transplant Direct. 2017 Dec; 3(12):e225. View in PubMed
  5. Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY. Misdiagnosis of hepatocellular carcinoma in patients receiving no local-regional therapy prior to liver transplant: An analysis of the Organ Procurement and Transplantation Network explant pathology form. Clin Transplant. 2017 Nov; 31(11). View in PubMed
  6. Orandi BJ, Luo X, King EA, Garonzik-Wang JM, Bae S, Montgomery RA, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Osama Gaber A, Segev DL. Hospital readmissions following HLA-incompatible live donor kidney transplantation: A multi-center study. Am J Transplant. 2018 Mar; 18(3):650-658. View in PubMed
  7. Mehta N, Heimbach J, Lee D, Dodge JL, Harnois D, Burns J, Sanchez W, Roberts JP, Yao FY. Wait Time of Less Than 6 and Greater Than 18 Months Predicts Hepatocellular Carcinoma Recurrence After Liver Transplantation: Proposing a Wait Time "Sweet Spot". Transplantation. 2017 09; 101(9):2071-2078. View in PubMed
  8. Radhakrishnan K, Chi A, Quan DJ, Roberts JP, Terrault NA. Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients. Transplantation. 2017 09; 101(9):2079-2082. View in PubMed
  9. Samoylova ML, Nigrini MJ, Dodge JL, Roberts JP. Biases in the reporting of hepatocellular carcinoma tumor sizes on the liver transplant waiting list. Hepatology. 2017 10; 66(4):1144-1150. View in PubMed
  10. Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, Feng S. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology. 2017 08; 66(2):564-574. View in PubMed
  11. Lewin SM, Mehta N, Kelley RK, Roberts JP, Yao FY, Brandman D. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma. Liver Transpl. 2017 Aug; 23(8):1015-1022. View in PubMed
  12. Ge J, Roberts JP, Lai JC. Race/ethnicity is associated with ABO-nonidentical liver transplantation in the United States. Clin Transplant. 2017 Aug; 31(8). View in PubMed
  13. Salazar J, Saxena V, Kahn JG, Roberts JP, Mehta N, Volk M, Lai JC. Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C-Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular Carcinoma. Transplantation. 2017 05; 101(5):1001-1008. View in PubMed
  14. Mehta N, Heimbach J, Harnois DM, Sapisochin G, Dodge JL, Lee D, Burns JM, Sanchez W, Greig PD, Grant DR, Roberts JP, Yao FY. Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant. JAMA Oncol. 2017 Apr 01; 3(4):493-500. View in PubMed
  15. Samoylova ML, Covinsky KE, Haftek M, Kuo S, Roberts JP, Lai JC. Disability in patients with end-stage liver disease: Results from the functional assessment in liver transplantation study. Liver Transpl. 2017 Mar; 23(3):292-298. View in PubMed
  16. Cai L, Yeh BM, Westphalen AC, Roberts J, Wang ZJ. 3D T2-weighted and Gd-EOB-DTPA-enhanced 3D T1-weighted MR cholangiography for evaluation of biliary anatomy in living liver donors. Abdom Radiol (NY). 2017 Mar; 42(3):842-850. View in PubMed
  17. Choi WT, Jen KY, Wang D, Tavakol M, Roberts JP, Gill RM. Donor Liver Small Droplet Macrovesicular Steatosis Is Associated With Increased Risk for Recipient Allograft Rejection. Am J Surg Pathol. 2017 Mar; 41(3):365-373. View in PubMed
  18. Hart A, Schladt DP, Zeglin J, Pyke J, Kim WR, Lake JR, Roberts JP, Hirose R, Mulligan DC, Kasiske BL, Snyder JJ, Israni AK. Predicting Outcomes on the Liver Transplant Waiting List in the United States: Accounting for Large Regional Variation in Organ Availability and Priority Allocation Points. Transplantation. 2016 10; 100(10):2153-9. View in PubMed
  19. Melcher ML, Roberts JP, Leichtman AB, Roth AE, Rees MA. We Need to Take the Next Step. Am J Transplant. 2016 Dec; 16(12):3581-3582. View in PubMed
  20. Braun HJ, Ascher NL, Roll GR, Roberts JP. Biliary complications following living donor hepatectomy. Transplant Rev (Orlando). 2016 10; 30(4):247-52. View in PubMed
  21. Pomposelli JJ, Goodrich NP, Emond JC, Humar A, Baker TB, Grant DR, Fisher RA, Roberts JP, Olthoff KM, Gillespie BW, Merion RM. Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience. Transplantation. 2016 Jul; 100(7):1490-9. View in PubMed
  22. Sarkar M, Dodge JL, Roberts JP, Terrault N, Yao F, Mehta N.  Increased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplant. Ann Hepatol. 2016 Jul-Aug; 15(4):545-9. View in PubMed
  23. Braun HJ, Perito ER, Dodge JL, Rhee S, Roberts JP. Nonstandard Exception Requests Impact Outcomes for Pediatric Liver Transplant Candidates. Am J Transplant. 2016 11; 16(11):3181-3191. View in PubMed
  24. Braun HJ, Dodge JL, Roll GR, Freise CE, Ascher NL, Roberts JP. Impact of Graft Selection on Donor and Recipient Outcomes After Living Donor Liver Transplantation. Transplantation. 2016 06; 100(6):1244-50. View in PubMed
  25. Cai L, Yeh BM, Westphalen AC, Roberts JP, Wang ZJ. Adult living donor liver imaging. Diagn Interv Radiol. 2016 May-Jun; 22(3):207-14. View in PubMed
  26. Mehta N, Roberts JP, Yao FY. Lack of benefits of mammalian target of rapamycin inhibitor in patients transplanted for hepatocellular carcinoma: Is this the end of the story? Liver Transpl. 2016 05; 22(5):582-4. View in PubMed
  27. Lai JC, Roberts JP. ABO-Nonidentical Liver Transplantation in the United States. Am J Transplant. 2016 08; 16(8):2430-6. View in PubMed
  28. Lai JC, Covinsky KE, Hayssen H, Lizaola B, Dodge J, Roberts JP, Terrault NA, Feng S. Response to clinical assessments of health status as a potential marker to identify patients who are too sick to undergo transplantation. Liver Int. 2016 Apr; 36(4):611. View in PubMed
  29. Orandi BJ, Luo X, Massie AB, Garonzik-Wang JM, Lonze BE, Ahmed R, Van Arendonk KJ, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Gaber AO, Montgomery RA, Segev DL. Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors. N Engl J Med. 2016 Mar 10; 374(10):940-50. View in PubMed
  30. Melcher ML, Roberts JP, Leichtman AB, Roth AE, Rees MA. Utilization of Deceased Donor Kidneys to Initiate Living Donor Chains. Am J Transplant. 2016 05; 16(5):1367-70. View in PubMed
  31. Roberts JP. The Cost of Fairness. Am J Transplant. 2016 Feb; 16(2):385-6. View in PubMed
  32. Mehta N, Sarkar M, Dodge JL, Fidelman N, Roberts JP, Yao FY. Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing. Liver Transpl. 2016 Feb; 22(2):178-87. View in PubMed
  33. Mehta N, Heimbach J, Hirose R, Roberts JP, Yao FY. Minimal Transplant Survival Benefit for Hepatocellular Carcinoma: Is it Real or an Overestimation of Waitlist Life Expectancy? Gastroenterology. 2016 Feb; 150(2):533-4. View in PubMed
  34. Olmos A, Feiner J, Hirose R, Swain S, Blasi A, Roberts JP, Niemann CU. Impact of a quality improvement project on deceased organ donor management. Prog Transplant. 2015 Dec; 25(4):351-60. View in PubMed
  35. Kwong AJ, Lai JC, Dodge JL, Roberts JP. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score. Liver Transpl. 2015 Nov; 21(11):1403-9. View in PubMed
  36. Roberts JP. Transplantation: Allocation of liver transplants-a road to consensus. Nat Rev Gastroenterol Hepatol. 2015 Nov; 12(11):615-6. View in PubMed
  37. Held PJ, McCormick F, Ojo A, Roberts JP. A Cost-Benefit Analysis of Government Compensation of Kidney Donors. Am J Transplant. 2016 Mar; 16(3):877-85. View in PubMed
  38. Axelrod DA, Vagefi PA, Roberts JP. The Evolution of Organ Allocation for Liver Transplantation: Tackling Geographic Disparity Through Broader Sharing. Ann Surg. 2015 Aug; 262(2):224-7. View in PubMed
  39. Niemann CU, Feiner J, Swain S, Bunting S, Friedman M, Crutchfield M, Broglio K, Hirose R, Roberts JP, Malinoski D. Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function. N Engl J Med. 2015 Jul 30; 373(5):405-14. View in PubMed
  40. Macdonald B, Sewell JL, Harper AM, Roberts JP, Yao FY. Liver transplantation for hepatocellular carcinoma: analysis of factors predicting outcome in 1074 patients in OPTN Region 5. Clin Transplant. 2015 Jun; 29(6):506-12. View in PubMed
  41. Yao FY, Mehta N, Flemming J, Dodge J, Hameed B, Fix O, Hirose R, Fidelman N, Kerlan RK, Roberts JP. Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria. Hepatology. 2015 Jun; 61(6):1968-77. View in PubMed
  42. Lai JC, Covinsky KE, Hayssen H, Lizaola B, Dodge JL, Roberts JP, Terrault NA, Feng S. Clinician assessments of health status predict mortality in patients with end-stage liver disease awaiting liver transplantation. Liver Int. 2015 Sep; 35(9):2167-73. View in PubMed
  43. Vagefi PA, Dodge JL, Yao FY, Roberts JP. Potential role of the donor in hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl. 2015 Feb; 21(2):187-94. View in PubMed
  44. Samoylova ML, Dodge JL, Mehta N, Yao FY, Roberts JP. Evaluating the validity of model for end-stage liver disease exception points for hepatocellular carcinoma patients with multiple nodules <2 cm. Clin Transplant. 2015 Jan; 29(1):52-9. View in PubMed
  45. Roberts JP. Does center-specific reporting limit innovation. Liver Transpl. 2014 Nov; 20 Suppl 2:S42-4. View in PubMed
  46. Feng K, Gupta V, Terrazas E, Yeghiazarians Y, Ports T, Gregoratos G, Tavakol M, Roberts JP, Boyle A. Trans-radial versus trans-femoral access in patients with end-stage liver disease undergoing cardiac catheterization. Am J Cardiovasc Dis. 2014; 4(3):133-9. View in PubMed
  47. Goel A, Mehta N, Guy J, Fidelman N, Yao F, Roberts J, Terrault N. Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization. Liver Transpl. 2014 Oct; 20(10):1221-8. View in PubMed
  48. Yao FY, Hameed B, Mehta N, Roberts JP. Response to letter to the editors. Liver Transpl. 2014 Oct; 20(10):1285. View in PubMed
  49. Hameed B, Mehta N, Sapisochin G, Roberts JP, Yao FY. Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria. Liver Transpl. 2014 Aug; 20(8):945-51. View in PubMed
  50. Samoylova ML, Dodge JL, Yao FY, Roberts JP. Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl. 2014 Aug; 20(8):937-44. View in PubMed
  51. Orandi BJ, Garonzik-Wang JM, Massie AB, Zachary AA, Montgomery JR, Van Arendonk KJ, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Gaber AO, Montgomery RA, Segev DL. Quantifying the risk of incompatible kidney transplantation: a multicenter study. Am J Transplant. 2014 Jul; 14(7):1573-80. View in PubMed
  52. Vagefi PA, Feng S, Dodge JL, Markmann JF, Roberts JP. Multiple listings as a reflection of geographic disparity in liver transplantation. J Am Coll Surg. 2014 Sep; 219(3):496-504. View in PubMed
  53. Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY. Outcomes after liver transplantation for patients with hepatocellular carcinoma and a low risk of dropout from the transplant waiting list. Liver Transpl. 2014 May; 20(5):627-8. View in PubMed
  54. Lai JC, Kahn JG, Roberts JP. Author response: reducing infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysis. Am J Transplant. 2014 Apr; 14(4):981. View in PubMed
  55. Asrani SK, Wiesner RH, Trotter JF, Klintmalm G, Katz E, Maller E, Roberts J, Kneteman N, Teperman L, Fung JJ, Millis JM. De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. Am J Transplant. 2014 Feb; 14(2):356-66. View in PubMed
  56. Roll GR, Roberts JP. Left versus right lobe liver donation. Am J Transplant. 2014 Feb; 14(2):251-2. View in PubMed
  57. Mehta N, Dodge JL, Goel A, Roberts JP, Hirose R, Yao FY. Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy. Liver Transpl. 2013 Dec; 19(12):1343-53. View in PubMed
  58. Perito ER, Rhee S, Roberts JP, Rosenthal P. Pediatric liver transplantation for urea cycle disorders and organic acidemias: United Network for Organ Sharing data for 2002-2012. Liver Transpl. 2014 Jan; 20(1):89-99. View in PubMed
  59. Neidich E, Neidich AB, Axelrod DA, Roberts JP. Consumerist responses to scarcity of organs for transplant. Virtual Mentor. 2013 Nov 01; 15(11):966-72. View in PubMed
  60. Samoylova ML, Dodge JL, Vittinghoff E, Yao FY, Roberts JP. Validating posttransplant hepatocellular carcinoma recurrence data in the United Network for Organ Sharing database. Liver Transpl. 2013 Dec; 19(12):1318-23. View in PubMed
  61. Rabe IB, Schwartz BS, Farnon EC, Josephson SA, Webber AB, Roberts JP, de Mattos AM, Gallay BJ, van Slyck S, Messenger SL, Yen CJ, Bloch EM, Drew CP, Fischer M, Glaser CA. Fatal transplant-associated west nile virus encephalitis and public health investigation-california, 2010. Transplantation. 2013 Sep 15; 96(5):463-8. View in PubMed
  62. Halldorson J, Roberts JP. Decadal analysis of deceased organ donation in Spain and the United States linking an increased donation rate and the utilization of older donors. Liver Transpl. 2013 Sep; 19(9):981-6. View in PubMed
  63. Lai JC, Kahn JG, Tavakol M, Peters MG, Roberts JP. Reducing infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysis. Am J Transplant. 2013 Oct; 13(10):2611-8. View in PubMed
  64. Teperman L, Moonka D, Sebastian A, Sher L, Marotta P, Marsh C, Koneru B, Goss J, Preston D, Roberts JP. Calcineurin inhibitor-free mycophenolate mofetil/sirolimus maintenance in liver transplantation: the randomized spare-the-nephron trial. Liver Transpl. 2013 Jul; 19(7):675-89. View in PubMed
  65. Keedy AW, Breiman RS, Webb EM, Roberts JP, Coakley FV, Yeh BM. Determinants of second-order bile duct visualization at CT cholangiography in potential living liver donors. AJR Am J Roentgenol. 2013 May; 200(5):1028-33. View in PubMed
  66. Vagefi PA, Parekh J, Ascher NL, Roberts JP, Freise CE. Ex vivo split-liver transplantation: the true right/left split. HPB (Oxford). 2014 Mar; 16(3):267-74. View in PubMed
  67. Roll GR, Parekh JR, Parker WF, Siegler M, Pomfret EA, Ascher NL, Roberts JP. Left hepatectomy versus right hepatectomy for living donor liver transplantation: shifting the risk from the donor to the recipient. Liver Transpl. 2013 May; 19(5):472-81. View in PubMed
  68. Hickey MD, Quan DJ, Chin-Hong PV, Roberts JP. Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation. Liver Transpl. 2013 Apr; 19(4):457-61. View in PubMed
  69. Lai JC, Feng S, Vittinghoff E, Roberts JP. Offer patterns of nationally placed livers by donation service area. Liver Transpl. 2013 Apr; 19(4):404-10. View in PubMed
  70. Halldorson JB, Paarsch HJ, Dodge JL, Segre AM, Lai J, Roberts JP. Center competition and outcomes following liver transplantation. Liver Transpl. 2013 Jan; 19(1):96-104. View in PubMed
  71. Biggins SW, Bambha KM, Terrault NA, Inadomi J, Shiboski S, Dodge JL, Gralla J, Rosen HR, Roberts JP. Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma. Liver Transpl. 2012 Dec; 18(12):1471-8. View in PubMed
  72. Roberts JP. Impact of outcomes monitoring on innovation and risk in liver transplantation. Liver Transpl. 2012 Nov; 18 Suppl 2:S59-63. View in PubMed
  73. Rothbaum Perito E, Lau A, Rhee S, Roberts JP, Rosenthal P. Posttransplant metabolic syndrome in children and adolescents after liver transplantation: a systematic review. Liver Transpl. 2012 Sep; 18(9):1009-28. View in PubMed
  74. Perito ER, Rhee S, Glidden D, Roberts JP, Rosenthal P. Impact of the donor body mass index on the survival of pediatric liver transplant recipients and post-transplant obesity. Liver Transpl. 2012 Aug; 18(8):930-9. View in PubMed
  75. Lai JC, Feng S, Roberts JP. An examination of liver offers to candidates on the liver transplant wait-list. Gastroenterology. 2012 Nov; 143(5):1261-5. View in PubMed
  76. Melcher ML, Leeser DB, Gritsch HA, Milner J, Kapur S, Busque S, Roberts JP, Katznelson S, Bry W, Yang H, Lu A, Mulgaonkar S, Danovitch GM, Hil G, Veale JL. Chain transplantation: initial experience of a large multicenter program. Am J Transplant. 2012 Sep; 12(9):2429-36. View in PubMed
  77. Park SJ, Freise CE, Hirose R, Kerlan RK, Yao FY, Roberts JP, Vagefi PA. Risk factors for liver transplant waitlist dropout in patients with hepatocellular carcinoma. Clin Transplant. 2012 Jul-Aug; 26(4):E359-64. View in PubMed
  78. Kasiske BL, McBride MA, Cornell DL, Gaston RS, Henry ML, Irwin FD, Israni AK, Metzler NW, Murphy KW, Reed AI, Roberts JP, Salkowski N, Snyder JJ, Sweet SC. Report of a consensus conference on transplant program quality and surveillance. Am J Transplant. 2012 Aug; 12(8):1988-96. View in PubMed
  79. Lai JC, Roberts JP, Vittinghoff E, Terrault NA, Feng S. Patient, center and geographic characteristics of nationally placed livers. Am J Transplant. 2012 Apr; 12(4):947-53. View in PubMed
  80. Vagefi PA, Ascher NL, Freise CE, Dodge JL, Roberts JP. Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation. Liver Transpl. 2012 Feb; 18(2):160-5. View in PubMed
  81. Feng S, Ekong UD, Lobritto SJ, Demetris AJ, Roberts JP, Rosenthal P, Alonso EM, Philogene MC, Ikle D, Poole KM, Bridges ND, Turka LA, Tchao NK. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA. 2012 Jan 18; 307(3):283-93. View in PubMed
  82. Brandman D, Pingitore A, Lai JC, Roberts JP, Ferrell L, Bass NM, Terrault NA. Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus. Liver Transpl. 2011 Dec; 17(12):1380-6. View in PubMed
  83. Klintmalm GB, Davis GL, Teperman L, Netto GJ, Washburn K, Rudich SM, Pomfret EA, Vargas HE, Brown R, Eckhoff D, Pruett TL, Roberts J, Mulligan DC, Charlton MR, Heffron TG, Ham JM, Douglas DD, Sher L, Baliga PK, Kinkhabwala M, Koneru B, Abecassis M, Millis M, Jennings LW, Fasola CG. A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C. Liver Transpl. 2011 Dec; 17(12):1394-403. View in PubMed
  84. Flohr TR, Bonatti H, Hranjec T, Keith DS, Lobo PI, Kumer SC, Schmitt TM, Sawyer RG, Pruett TL, Roberts JP, Brayman KL. Elderly recipients of hepatitis C positive renal allografts can quickly develop liver disease. J Surg Res. 2012 Aug; 176(2):629-38. View in PubMed
  85. Perito ER, Glidden D, Roberts JP, Rosenthal P. Overweight and obesity in pediatric liver transplant recipients: prevalence and predictors before and after transplant, United Network for Organ Sharing Data, 1987-2010. Pediatr Transplant. 2012 Feb; 16(1):41-9. View in PubMed
  86. Guy J, Kelley RK, Roberts J, Kerlan R, Yao F, Terrault N. Multidisciplinary management of hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2012 Apr; 10(4):354-62. View in PubMed
  87. Living kidney donor follow-up: state-of-the-art and future directions, conference summary and recommendations. Am J Transplant. 2011 Dec; 11(12):2561-8. View in PubMed
  88. Brandman D, Biggins SW, Hameed B, Roberts JP, Terrault NA. Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality. Liver Int. 2012 Jan; 32(1):158-64. View in PubMed
  89. Washburn K, Pomfret E, Roberts J. Liver allocation and distribution: possible next steps. Liver Transpl. 2011 Sep; 17(9):1005-12. View in PubMed
  90. Vagefi PA, Parekh J, Ascher NL, Roberts JP, Freise CE. Outcomes with split liver transplantation in 106 recipients: the University of California, San Francisco, experience from 1993 to 2010. Arch Surg. 2011 Sep; 146(9):1052-9. View in PubMed
  91. Mast DA, Vaughan W, Busque S, Veale JL, Roberts JP, Straube BM, Flores N, Canari C, Levy E, Tietjen A, Hil G, Melcher ML. Managing finances of shipping living donor kidneys for donor exchanges. Am J Transplant. 2011 Sep; 11(9):1810-4. View in PubMed
  92. Sapisochin G, Yao FY, Roberts JP. Do preoperative inflammatory markers impact on outcome after liver transplantation for hepatocellular carcinoma? Ann Surg. 2011 Aug; 254(2):383; author reply 383-4. View in PubMed
  93. Coffin CS, Mulrooney-Cousins PM, van Marle G, Roberts JP, Michalak TI, Terrault NA. Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy. Liver Transpl. 2011 Aug; 17(8):955-62. View in PubMed
  94. Sapisochin G, Fidelman N, Roberts JP, Yao FY. Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transpl. 2011 Aug; 17(8):934-42. View in PubMed
  95. Kwan SW, Fidelman N, Durack JC, Roberts JP, Kerlan RK. Rex shunt preoperative imaging: diagnostic capability of imaging modalities. PLoS One. 2011; 6(7):e22222. View in PubMed
  96. Ahearn AJ, Posselt AM, Kang SM, Roberts JP, Freise CE. Experience with laparoscopic donor nephrectomy among more than 1000 cases: low complication rates, despite more challenging cases. Arch Surg. 2011 Jul; 146(7):859-64. View in PubMed
  97. Ashby VB, Port FK, Wolfe RA, Wynn JJ, Williams WW, Roberts JP, Leichtman AB. Transplanting kidneys without points for HLA-B matching: consequences of the policy change. Am J Transplant. 2011 Aug; 11(8):1712-8. View in PubMed
  98. Coffin CS, Mulrooney-Cousins PM, Peters MG, van Marle G, Roberts JP, Michalak TI, Terrault NA. Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy. J Viral Hepat. 2011 Jun; 18(6):415-23. View in PubMed
  99. Martinez AF, Bonacini M, Roberts JP. Image of the month. Portal hypertensive biliopathy. Arch Surg. 2011 May; 146(5):625-6. View in PubMed
  100. Ladabaum U, Cheng SL, Yao FY, Roberts JP. Cost-effectiveness of screening for recurrent hepatocellular carcinoma after liver transplantation. Clin Transplant. 2011 Mar-Apr; 25(2):283-91. View in PubMed
  101. Reich DJ, Magee JC, Gifford K, Merion RM, Roberts JP, Klintmalm GB, Stock PG. Transplant surgery fellow perceptions about training and the ensuing job market-are the right number of surgeons being trained? Am J Transplant. 2011 Feb; 11(2):253-60. View in PubMed
  102. Durack J, Bass N, Teitel D, Kerlan R, Roberts J. Endovascular closure of a portocaval shunt after left lobe liver transplantation using an Amplatzer muscular ventricular septal occluder device. Liver Transpl. 2011 Feb; 17(2):211-4. View in PubMed
  103. Lai JC, Feng S, Roberts JP, Terrault NA. Gender differences in liver donor quality are predictive of graft loss. Am J Transplant. 2011 Feb; 11(2):296-302. View in PubMed
  104. Segev DL, Veale JL, Berger JC, Hiller JM, Hanto RL, Leeser DB, Geffner SR, Shenoy S, Bry WI, Katznelson S, Melcher ML, Rees MA, Samara EN, Israni AK, Cooper M, Montgomery RJ, Malinzak L, Whiting J, Baran D, Tchervenkov JI, Roberts JP, Rogers J, Axelrod DA, Simpkins CE, Montgomery RA. Transporting live donor kidneys for kidney paired donation: initial national results. Am J Transplant. 2011 Feb; 11(2):356-60. View in PubMed
  105. Cendales L, Granger D, Henry M, Jones J, Langnas A, Levi D, Magee J, Merion R, Olthoff K, Pruett T, Roberts J, Abecassis M. Implementation of vascularized composite allografts in the United States: recommendations from the ASTS VCA Ad Hoc Committee and the Executive Committee. Am J Transplant. 2011 Jan; 11(1):13-7. View in PubMed
  106. Yong CM, Sharma M, Ochoa V, Abnousi F, Roberts J, Bass NM, Niemann CU, Shiboski S, Prasad M, Tavakol M, Ports TA, Gregoratos G, Yeghiazarians Y, Boyle AJ. Multivessel coronary artery disease predicts mortality, length of stay, and pressor requirements after liver transplantation. Liver Transpl. 2010 Nov; 16(11):1242-8. View in PubMed
  107. Melcher ML, Freise CE, Ascher NL, Roberts JP. Outcomes of surgical repair of bile leaks and strictures after adult-to-adult living donor liver transplant. Clin Transplant. 2010 Nov-Dec; 24(6):E230-5. View in PubMed
  108. Melcher ML, Pomposelli JJ, Verbesey JE, McTaggart RA, Freise CE, Ascher NL, Roberts JP, Pomfret EA. Comparison of biliary complications in adult living-donor liver transplants performed at two busy transplant centers. Clin Transplant. 2010 Sep-Oct; 24(5):E137-44. View in PubMed
  109. Burnett MM, Hess CP, Roberts JP, Bass NM, Douglas VC, Josephson SA. Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors. Clin Neurol Neurosurg. 2010 Dec; 112(10):886-91. View in PubMed
  110. Roberts JP, Venook A, Kerlan R, Yao F. Hepatocellular carcinoma: Ablate and wait versus rapid transplantation. Liver Transpl. 2010 Aug; 16(8):925-9. View in PubMed
  111. Botha JF, Langnas AN, Campos BD, Grant WJ, Freise CE, Ascher NL, Mercer DF, Roberts JP. Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome. Liver Transpl. 2010 May; 16(5):649-57. View in PubMed
  112. Niemann CU, Walia A, Waldman J, Davio M, Roberts JP, Hirose R, Feiner J. Acute kidney injury during liver transplantation as determined by neutrophil gelatinase-associated lipocalin. Liver Transpl. 2009 Dec; 15(12):1852-60. View in PubMed
  113. Washburn WK, Meo NA, Halff GA, Roberts JP, Feng S. Factors influencing liver transplant length of stay at two large-volume transplant centers. Liver Transpl. 2009 Nov; 15(11):1570-8. View in PubMed
  114. Reed AI, Merion RM, Roberts JP, Klintmalm GB, Abecassis MM, Olthoff KM, Langnas AN. The Declaration of Istanbul: review and commentary by the American Society of Transplant Surgeons Ethics Committee and Executive Committee. Am J Transplant. 2009 Nov; 9(11):2466-9. View in PubMed
  115. Tavakol MM, Vincenti FG, Assadi H, Frederick MJ, Tomlanovich SJ, Roberts JP, Posselt AM. Long-term renal function and cardiovascular disease risk in obese kidney donors. Clin J Am Soc Nephrol. 2009 Jul; 4(7):1230-8. View in PubMed
  116. Blasi-Ibanez A, Hirose R, Feiner J, Freise C, Stock PG, Roberts JP, Niemann CU. Predictors associated with terminal renal function in deceased organ donors in the intensive care unit. Anesthesiology. 2009 Feb; 110(2):333-41. View in PubMed
  117. Sharma M, Yong C, Majure D, Zellner C, Roberts JP, Bass NM, Ports TA, Yeghiazarians Y, Gregoratos G, Boyle AJ. Safety of cardiac catheterization in patients with end-stage liver disease awaiting liver transplantation. Am J Cardiol. 2009 Mar 01; 103(5):742-6. View in PubMed
  118. Biggins SW, Bambha K, Terrault N, Inadomi J, Roberts JP, Bass N. Transplant tourism to China: the impact on domestic patient-care decisions. Clin Transplant. 2009 Nov-Dec; 23(6):831-8. View in PubMed
  119. Kuo A, Tan V, Lan B, Khalili M, Feng S, Roberts JP, Terrault NA. Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection. Liver Transpl. 2008 Oct; 14(10):1491-7. View in PubMed
  120. Yao FY, Kerlan RK, Hirose R, Davern TJ, Bass NM, Feng S, Peters M, Terrault N, Freise CE, Ascher NL, Roberts JP. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology. 2008 Sep; 48(3):819-27. View in PubMed
  121. Breiman RS, Coakley FV, Webb EM, Ellingson JJ, Roberts JP, Kohr J, Lutz J, Knoess N, Yeh BM. CT cholangiography in potential liver donors: effect of premedication with intravenous morphine on biliary caliber and visualization. Radiology. 2008 Jun; 247(3):733-7. View in PubMed
  122. Ponrartana S, Coakley FV, Yeh BM, Breiman RS, Qayyum A, Joe BN, Poder L, Lu Y, Gibbs VC, Roberts JP. Accuracy of plain abdominal radiographs in the detection of retained surgical needles in the peritoneal cavity. Ann Surg. 2008 Jan; 247(1):8-12. View in PubMed
  123. Roland ME, Barin B, Carlson L, Frassetto LA, Terrault NA, Hirose R, Freise CE, Benet LZ, Ascher NL, Roberts JP, Murphy B, Keller MJ, Olthoff KM, Blumberg EA, Brayman KL, Bartlett ST, Davis CE, McCune JM, Bredt BM, Stablein DM, Stock PG. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant. 2008 Feb; 8(2):355-65. View in PubMed
  124. Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant. 2007 Nov; 7(11):2587-96. View in PubMed
  125. Chao SD, Roberts JP, Farr M, Yao FY. Short waitlist time does not adversely impact outcome following liver transplantation for hepatocellular carcinoma. Am J Transplant. 2007 Jun; 7(6):1594-600. View in PubMed
  126. Niemann CU, Feiner J, Behrends M, Eilers H, Ascher NL, Roberts JP. Central venous pressure monitoring during living right donor hepatectomy. Liver Transpl. 2007 Feb; 13(2):266-71. View in PubMed
  127. Yeh BM, Coakley FV, Westphalen AC, Joe BN, Freise CE, Qayyum A, McTaggart RA, Roberts JP. Predicting biliary complications in right lobe liver transplant recipients according to distance between donor's bile duct and corresponding hepatic artery. Radiology. 2007 Jan; 242(1):144-51. View in PubMed
  128. O'Brien MJ, Bloom A, LaBerge JM, Roberts JP, Rosenthal P, Kerlan RK. SIR 2006 Annual Meeting Film Panel Case: Budd-Chiari syndrome in a patient with Cogan syndrome. J Vasc Interv Radiol. 2006 Dec; 17(12):1881-3. View in PubMed
  129. Roberts JP, Neill A, Goldstein R. The use of a micro-bubble contrast agent to allow visualization of the biliary tree. Clin Transplant. 2006 Nov-Dec; 20(6):740-2. View in PubMed
  130. Roberts JP, Dykstra DM, Goodrich NP, Rush SH, Merion RM, Port FK. Geographic differences in event rates by model for end-stage liver disease score. Am J Transplant. 2006 Oct; 6(10):2470-5. View in PubMed
  131. Yao FY, Gautam M, Palese C, Rebres R, Terrault N, Roberts JP, Peters MG. De novo malignancies following liver transplantation: a case-control study with long-term follow-up. Clin Transplant. 2006 Sep-Oct; 20(5):617-23. View in PubMed
  132. Niemann CU, Choi S, Behrends M, Hirose R, Noh J, Coatney JL, Roberts JP, Serkova NJ, Maher JJ. Mild hypothermia protects obese rats from fulminant hepatic necrosis induced by ischemia-reperfusion. Surgery. 2006 Sep; 140(3):404-12. View in PubMed
  133. Niemann CU, Behrends M, Quan D, Eilers H, Gropper MA, Roberts JP, Hirose R. Recombinant factor VIIa reduces transfusion requirements in liver transplant patients with high MELD scores. Transfus Med. 2006 Apr; 16(2):93-100. View in PubMed
  134. Feng S, Si M, Taranto SE, McBride MA, Mudge C, Stritzel S, Roberts JP, Rosenthal P. Trends over a decade of pediatric liver transplantation in the United States. Liver Transpl. 2006 Apr; 12(4):578-84. View in PubMed
  135. Hirsch J, Hansen KC, Choi S, Noh J, Hirose R, Roberts JP, Matthay MA, Burlingame AL, Maher JJ, Niemann CU. Warm ischemia-induced alterations in oxidative and inflammatory proteins in hepatic Kupffer cells in rats. Mol Cell Proteomics. 2006 Jun; 5(6):979-86. View in PubMed
  136. Khalili M, Vardanian AJ, Hamerski CM, Wang R, Bacchetti P, Roberts JP, Terrault NA. Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years. Clin Transplant. 2006 Jan-Feb; 20(1):1-9. View in PubMed
  137. Niemann CU, Hirose R, Liu T, Behrends M, Brown JL, Kominsky DF, Roberts JP, Serkova N. Ischemic preconditioning improves energy state and transplantation survival in obese Zucker rat livers. Anesth Analg. 2005 Dec; 101(6):1577-83. View in PubMed
  138. Yao FY, Hirose R, LaBerge JM, Davern TJ, Bass NM, Kerlan RK, Merriman R, Feng S, Freise CE, Ascher NL, Roberts JP. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl. 2005 Dec; 11(12):1505-14. View in PubMed
  139. Carter JT, Chan S, Roberts JP, Feng S. Expanded criteria donor kidney allocation: marked decrease in cold ischemia and delayed graft function at a single center. Am J Transplant. 2005 Nov; 5(11):2745-53. View in PubMed
  140. Roberts JP. Tumor surveillance-what can and should be done? Screening for recurrence of hepatocellular carcinoma after liver transplantation. Liver Transpl. 2005 Nov; (11 Suppl 2):S45-6. View in PubMed
  141. Cruz E, Ascher NL, Roberts JP, Bass NM, Yao FY. High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome. Clin Transplant. 2005 Aug; 19(4):501-6. View in PubMed
  142. Carter JT, Freise CE, McTaggart RA, Mahanty HD, Kang SM, Chan SH, Feng S, Roberts JP, Posselt AM. Laparoscopic procurement of kidneys with multiple renal arteries is associated with increased ureteral complications in the recipient. Am J Transplant. 2005 Jun; 5(6):1312-8. View in PubMed
  143. Wang ZJ, Yeh BM, Roberts JP, Breiman RS, Qayyum A, Coakley FV. Living donor candidates for right hepatic lobe transplantation: evaluation at CT cholangiography--initial experience. Radiology. 2005 Jun; 235(3):899-904. View in PubMed
  144. Yao FY, Kinkhabwala M, LaBerge JM, Bass NM, Brown R, Kerlan R, Venook A, Ascher NL, Emond JC, Roberts JP. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant. 2005 Apr; 5(4 Pt 1):795-804. View in PubMed
  145. Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology. 2005 Jan; 41(1):32-9. View in PubMed
  146. Chen JS, Yeh BM, Wang ZJ, Roberts JP, Breiman RS, Qayyum A, Coakley FV. Concordance of second-order portal venous and biliary tract anatomies on MDCT angiography and MDCT cholangiography. AJR Am J Roentgenol. 2005 Jan; 184(1):70-4. View in PubMed
  147. Shergill AK, Khalili M, Straley S, Bollinger K, Roberts JP, Ascher NA, Terrault NA. Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. Am J Transplant. 2005 Jan; 5(1):118-24. View in PubMed
  148. Posselt AM, Mahanty H, Kang SM, Stoller ML, Meng MV, Roberts JP, Freise CE. Laparoscopic right donor nephrectomy: a large single-center experience. Transplantation. 2004 Dec 15; 78(11):1665-9. View in PubMed
  149. Vulchev A, Roberts JP, Stock PG. Ethical issues in split versus whole liver transplantation. Am J Transplant. 2004 Nov; 4(11):1737-40. View in PubMed
  150. Visser BC, Suh I, Hirose S, Rosenthal P, Lee H, Roberts JP, Hirose R. The influence of portoenterostomy on transplantation for biliary atresia. Liver Transpl. 2004 Oct; 10(10):1279-86. View in PubMed
  151. McTaggart RA, Tomlanovich S, Bostrom A, Roberts JP, Feng S. Comparison of outcomes after delayed graft function: sirolimus-based versus other calcineurin-inhibitor sparing induction immunosuppression regimens. Transplantation. 2004 Aug 15; 78(3):475-80. View in PubMed
  152. Miller GA, Yeh BM, Breiman RS, Roberts JP, Qayyum A, Coakley FV. Use of CT cholangiography to evaluate the biliary tract after liver transplantation: initial experience. Liver Transpl. 2004 Aug; 10(8):1065-70. View in PubMed
  153. Niemann CU, Hirose R, Stock P, Roberts JP, Mandell S, Spencer Yost C. Intraoperative fluid management of living donor versus cadaveric liver transplant recipients. Transplant Proc. 2004 Jun; 36(5):1466-8. View in PubMed
  154. Yao FY, Bass NM, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy. Liver Transpl. 2004 May; 10(5):621-30. View in PubMed
  155. Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault NA. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transpl. 2004 Mar; 10(3):349-55. View in PubMed
  156. Roberts JP, Hulbert-Shearon TE, Merion RM, Wolfe RA, Port FK. Influence of graft type on outcomes after pediatric liver transplantation. Am J Transplant. 2004 Mar; 4(3):373-7. View in PubMed
  157. Yeh BM, Breiman RS, Taouli B, Qayyum A, Roberts JP, Coakley FV. Biliary tract depiction in living potential liver donors: comparison of conventional MR, mangafodipir trisodium-enhanced excretory MR, and multi-detector row CT cholangiography--initial experience. Radiology. 2004 Mar; 230(3):645-51. View in PubMed
  158. Roberts JP, Wolfe RA, Bragg-Gresham JL, Rush SH, Wynn JJ, Distant DA, Ashby VB, Held PJ, Port FK. Effect of changing the priority for HLA matching on the rates and outcomes of kidney transplantation in minority groups. N Engl J Med. 2004 Feb 05; 350(6):545-51. View in PubMed
  159. Yao FY, Saab S, Bass NM, Hirose R, Ly D, Terrault N, Lazar AA, Bacchetti P, Ascher NL, Roberts JP. Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores. Hepatology. 2004 Jan; 39(1):230-8. View in PubMed
  160. Chang GJ, Mahanty HD, Ascher NL, Roberts JP. Expanding the donor pool: can the Spanish model work in the United States? Am J Transplant. 2003 Oct; 3(10):1259-63. View in PubMed
  161. Roberts JP, Nikolai B, Tomlanovich S. Cost of organ procurement and transplantation network data collection for a large transplant center. Am J Transplant. 2003 Oct; 3(10):1316-7. View in PubMed
  162. Roberts JP. Role of adult living liver donation in patients with hepatocellular cancer. Liver Transpl. 2003 Oct; 9(10 Suppl 2):S60-3. View in PubMed
  163. Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, Terrault NA, Frassetto LA, Palefsky JM, Tomlanovich SJ, Ascher NL. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation. 2003 Jul 27; 76(2):370-5. View in PubMed
  164. Posselt AM, Vincenti F, Bedolli M, Lantz M, Roberts JP, Hirose R. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients. Transplantation. 2003 Jul 15; 76(1):190-5. View in PubMed
  165. Yao FY, Bass NM, Nikolai B, Merriman R, Davern TJ, Kerlan R, Ascher NL, Roberts JP. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy. Liver Transpl. 2003 Jul; 9(7):684-92. View in PubMed
  166. McTaggart RA, Gottlieb D, Brooks J, Bacchetti P, Roberts JP, Tomlanovich S, Feng S. Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant. 2003 Apr; 3(4):416-23. View in PubMed
  167. Roberts JP, Brown RS, Edwards EB, Farmer DG, Freeman RB, Wiesner RH, Merion RM. Liver and intestine transplantation. Am J Transplant. 2003; 3 Suppl 4:78-90. View in PubMed
  168. Niemann CU, Roberts JP, Ascher NL, Yost CS. Intraoperative hemodynamics and liver function in adult-to-adult living liver donors. Liver Transpl. 2002 Dec; 8(12):1126-32. View in PubMed
  169. Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl. 2002 Oct; 8(10):873-83. View in PubMed
  170. Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl. 2002 Sep; 8(9):765-74. View in PubMed
  171. Toyoki Y, Renz JF, Mudge C, Ascher NL, Roberts JP, Rosenthal P. Allograft rejection in pediatric liver transplantation: Comparison between cadaveric and living related donors. Pediatr Transplant. 2002 Aug; 6(4):301-7. View in PubMed
  172. Chang GJ, Liu T, Feng S, Bedolli M, O'rourke RW, Schmidt G, Roberts JP, Stock PG. Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts. Surgery. 2002 Aug; 132(2):149-56. View in PubMed
  173. Renz JF, de Roos M, Rosenthal P, Mudge C, Bacchetti P, Watson J, Roberts JP, Ascher NL, Emond JC. Posttransplantation growth in pediatric liver recipients. Liver Transpl. 2001 Dec; 7(12):1040-55. View in PubMed
  174. Mahanty HD, Cherikh WS, Chang GJ, Baxter-Lowe LA, Roberts JP. Influence of pretransplant pregnancy on survival of renal allografts from living donors. Transplantation. 2001 Jul 27; 72(2):228-32. View in PubMed
  175. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001 Jun; 33(6):1394-403. View in PubMed
  176. Chang GJ, Mahanty HD, Vincenti F, Freise CE, Roberts JP, Ascher NL, Stock PG, Hirose R. A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function. Clin Transplant. 2000 Dec; 14(6):550-4. View in PubMed
  177. Chang GJ, Mahanty HD, Quan D, Freise CE, Ascher NL, Roberts JP, Stock PG, Hirose R. Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated. Liver Transpl. 2000 Nov; 6(6):734-40. View in PubMed
  178. Renz JF, Roberts JP. Long-term complications of living donor liver transplantation. Liver Transpl. 2000 Nov; 6(6 Suppl 2):S73-6. View in PubMed
  179. Lee CM, Carter JT, Alfrey EJ, Ascher NL, Roberts JP, Freise CE. Prolonged cold ischemia time obviates the benefits of 0 HLA mismatches in renal transplantation. Arch Surg. 2000 Sep; 135(9):1016-9; discussion 1019-20. View in PubMed
  180. O'Rourke RW, Osorio RW, Freise CE, Lou CD, Garovoy MR, Bacchetti P, Ascher NL, Melzer JS, Roberts JP, Stock PG. Flow cytometry crossmatching as a predictor of acute rejection in sensitized recipients of cadaveric renal transplants. Clin Transplant. 2000 Apr; 14(2):167-73. View in PubMed
  181. Hirose R, Roberts JP, Quan D, Osorio RW, Freise C, Ascher NL, Stock PG. Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation. Transplantation. 2000 Jan 27; 69(2):307-11. View in PubMed
  182. Yao FY, Osorio RW, Roberts JP, Poordad FF, Briceno MN, Garcia-Kennedy R, Gish RR. Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation. Liver Transpl Surg. 1999 Nov; 5(6):491-6. View in PubMed
  183. Renz JF, Lightdale J, Mudge C, Bacchetti P, Watson J, Ascher NL, Emond JC, Rosenthal P, Roberts JP. Mycophenolate mofetil, microemulsion cyclosporine, and prednisone as primary immunosuppression for pediatric liver transplant recipients. Liver Transpl Surg. 1999 Mar; 5(2):136-43. View in PubMed
  184. Freise CE, Ferrell L, Liu T, Ascher NL, Roberts JP. Effect of systemic cyclosporine on tumor recurrence after liver transplantation in a model of hepatocellular carcinoma. Transplantation. 1999 Feb 27; 67(4):510-3. View in PubMed
  185. Narumi S, Osorio RW, Freise CE, Stock PG, Roberts JP, Ascher NL. Hepatic artery pseudoaneurysm with hemobilia following angioplasty after liver transplantation. Clin Transplant. 1998 Dec; 12(6):508-10. View in PubMed
  186. Pessoa MG, Terrault NA, Ferrell LD, Detmer J, Kolberg J, Collins ML, Viele M, Lake JR, Roberts JP, Ascher NL, Wright TL. Hepatitis after liver transplantation: the role of the known and unknown viruses. Liver Transpl Surg. 1998 Nov; 4(6):461-8. View in PubMed
  187. Terrault NA, Zhou S, McCory RW, Pruett TL, Lake JR, Roberts JP, Ascher NL, Wright TL. Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology. 1998 Aug; 28(2):555-61. View in PubMed
  188. Lattyak BV, Rosenthal P, Mudge C, Roberts JP, Renze JF, Osorio RW, Emond JC, Lalwani AK. Posttransplant lymphoproliferative disorder presenting in the head and neck. Laryngoscope. 1998 Aug; 108(8 Pt 1):1195-8. View in PubMed
  189. Freise CE, Galbraith CA, Nikolai BJ, Ascher NL, Lake JR, Stock PG, Roberts JP. Risks associated with conversion of stable patients after liver transplantation to the microemulsion formulation of cyclosporine. Transplantation. 1998 Apr 15; 65(7):995-7. View in PubMed
  190. Rouillard SS, Bass NM, Roberts JP, Doherty CA, Gee L, Bacchetti P, Somberg KA. Severe hyperbilirubinemia after creation of transjugular intrahepatic portosystemic shunts: natural history and predictors of outcome. Ann Intern Med. 1998 Mar 01; 128(5):374-7. View in PubMed
  191. Roberts JP. T tube or no T tube? Liver Transpl Surg. 1997 Sep; 3(5 Suppl 1):S20-1. View in PubMed
  192. Renz JF, Rosenthal P, Roberts JP, Ascher NL, Emond JC. Planned exploration of pediatric liver transplant recipients reduces posttransplant morbidity and lowers length of hospitalization. Arch Surg. 1997 Sep; 132(9):950-5; discussion 955-6. View in PubMed
  193. Rosenthal P, Roberts JP, Ascher NL, Emond JC. Auxiliary liver transplant in fulminant failure. Pediatrics. 1997 Aug; 100(2):E10. View in PubMed
  194. Floren LC, Bekersky I, Benet LZ, Mekki Q, Dressler D, Lee JW, Roberts JP, Hebert MF. Tacrolimus oral bioavailability doubles with coadministration of ketoconazole. Clin Pharmacol Ther. 1997 Jul; 62(1):41-9. View in PubMed
  195. Pessoa MG, Terrault NA, Ferrell LD, Kim JP, Kolberg J, Detmer J, Collins ML, Yun AJ, Viele M, Lake JR, Roberts JP, Ascher NL, Wright TL. Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation. Hepatology. 1997 May; 25(5):1266-70. View in PubMed
  196. Terrault NA, Zhou S, Combs C, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology. 1996 Dec; 24(6):1327-33. View in PubMed
  197. Zhou S, Terrault NA, Ferrell L, Hahn JA, Lau JY, Simmonds P, Roberts JP, Lake JR, Ascher NL, Wright TL. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology. 1996 Nov; 24(5):1041-6. View in PubMed
  198. Emond JC, Renz JF, Ferrell LD, Rosenthal P, Lim RC, Roberts JP, Lake JR, Ascher NL. Functional analysis of grafts from living donors. Implications for the treatment of older recipients. Ann Surg. 1996 Oct; 224(4):544-52; discussion 552-4. View in PubMed
  199. Kuang AA, Renz JF, Ferrell LD, Ring EJ, Rosenthal P, Lim RC, Roberts JP, Ascher NL, Emond JC. Failure patterns of cryopreserved vein grafts in liver transplantation. Transplantation. 1996 Sep 27; 62(6):742-7. View in PubMed
  200. Roberts JP, Liu T, Freise CE, Mielczarek J, Ferrell L, Randall H, Ascher NL. Liver transplantation improves survival of rats bearing hepatoma-3924A. J Surg Res. 1996 Sep; 65(1):59-62. View in PubMed
  201. Emond JC, Stock P, Roberts JP, Ascher NL. Strategies for tolerance induction: potential applications in living donor liver transplantation. Transplant Proc. 1996 Aug; 28(4):2371-4. View in PubMed
  202. Emond JC, Rosenthal P, Roberts JP, Stock P, Kelley S, Gregory G, Lim RC, Ascher NL. Living related donor liver transplantation: the UCSF experience. Transplant Proc. 1996 Aug; 28(4):2375-7. View in PubMed
  203. Freise CE, Liu T, Ascher NL, Roberts JP. Hepatotoxins and liver transplantation decrease pulmonary metastases in rats with hepatoma. J Surg Res. 1996 Aug; 64(2):198-202. View in PubMed
  204. Kuang AA, Rosenthal P, Roberts JP, Renz JF, Stock P, Ascher NL, Emond JC. Decreased mortality from technical failure improves results in pediatric liver transplantation. Arch Surg. 1996 Aug; 131(8):887-92; discussion 892-3. View in PubMed
  205. Terrault NA, Holland CC, Ferrell L, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL. Interferon alfa for recurrent hepatitis B infection after liver transplantation. Liver Transpl Surg. 1996 Mar; 2(2):132-8. View in PubMed
  206. Emond JC, Kelley SD, Heffron TG, Nakagawa T, Roberts JP, Lim RC. Surgical and anesthetic management of patients undergoing major hepatectomy using total vascular exclusion. Liver Transpl Surg. 1996 Mar; 2(2):91-8. View in PubMed
  207. Croutch KL, Gordon RL, Ring EJ, Kerlan RK, LaBerge JM, Roberts JP. Superselective arterial embolization in the liver transplant recipient: a safe treatment for hemobilia caused by percutaneous transhepatic biliary drainage. Liver Transpl Surg. 1996 Mar; 2(2):118-23. View in PubMed
  208. Brown RS, Lake JR, Katzman BA, Ascher NL, Somberg KA, Emond JC, Roberts JP. Incidence and significance of Aspergillus cultures following liver and kidney transplantation. Transplantation. 1996 Feb 27; 61(4):666-9. View in PubMed
  209. Randall HB, Wachs ME, Somberg KA, Lake JR, Emond JC, Ascher NL, Roberts JP. The use of the T tube after orthotopic liver transplantation. Transplantation. 1996 Jan 27; 61(2):258-61. View in PubMed
  210. Gournay J, Ferrell LD, Roberts JP, Ascher NL, Wright TL, Lake JR. Cryoglobulinemia presenting after liver transplantation. Gastroenterology. 1996 Jan; 110(1):265-70. View in PubMed
  211. Ferrell LD, Roberts JP. Liver. Pathology (Phila). 1996; 3(2):367-78. View in PubMed
  212. Freise CE, Stock PG, Roberts JP, Melzer JS. Low postoperative wound infection rates are possible following simultaneous pancreas-kidney transplantation. Transplant Proc. 1995 Dec; 27(6):3069-70. View in PubMed
  213. Ferrell LD, Lee R, Brixko C, Bass NM, Lake JR, Roberts JP, Ascher N, Rabkin J. Hepatic granulomas following liver transplantation. Clinicopathologic features in 42 patients. Transplantation. 1995 Nov 15; 60(9):926-33. View in PubMed
  214. Freise CE, Liu T, Osorio RW, Ferrell L, Ascher NL, Roberts JP. Increased efficacy of CSA following rearterialization in the rat OLTX model. J Surg Res. 1995 Oct; 59(4):493-6. View in PubMed
  215. Renz JF, Mudge CL, Heyman MB, Tomlanovich S, Kingsford RP, Moore BJ, Snyder JD, Perr HA, Paschal AL, Roberts JP. Donor selection limits use of living-related liver transplantation. Hepatology. 1995 Oct; 22(4 Pt 1):1122-6. View in PubMed
  216. Wilson MW, Gordon RL, LaBerge JM, Kerlan RK, Radosevich PM, Roberts JP, Ring EJ. Liver transplantation complicated by malpositioned transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol. 1995 Sep-Oct; 6(5):695-9. View in PubMed
  217. Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL. Liver transplantation for sclerosing cholangitis. Hepatology. 1995 Aug; 22(2):451-7. View in PubMed
  218. Emond J, Wachs ME, Renz JF, Kelley S, Harris H, Roberts JP, Ascher NL, Lim RC. Total vascular exclusion for major hepatectomy in patients with abnormal liver parenchyma. Arch Surg. 1995 Aug; 130(8):824-30; discussion 830-1. View in PubMed
  219. Venook AP, Ferrell LD, Roberts JP, Emond J, Frye JW, Ring E, Ascher NL, Lake JR. Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization. Liver Transpl Surg. 1995 Jul; 1(4):242-8. View in PubMed
  220. Wacher VJ, Liu T, Roberts JP, Ascher NL, Benet LZ. Time course of cyclosporine and ist motabolites in blood, liver and spleen of naive Lewis rats: comparison with preliminary data obtained in transplanted animals. Biopharm Drug Dispos. 1995 May; 16(4):303-12. View in PubMed
  221. LaBerge JM, Somberg KA, Lake JR, Gordon RL, Kerlan RK, Ascher NL, Roberts JP, Simor MM, Doherty CA, Hahn J. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology. 1995 Apr; 108(4):1143-51. View in PubMed
  222. Somberg KA, Riegler JL, LaBerge JM, Doherty-Simor MM, Bachetti P, Roberts JP, Lake JR. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors. Am J Gastroenterol. 1995 Apr; 90(4):549-55. View in PubMed
  223. Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Melzer JS, Roberts JP, Tomlanovich SJ, Vincenti F. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation. 1995 Jan 27; 59(2):230-4. View in PubMed
  224. Osorio RW, Ascher NL, Avery M, Bacchetti P, Roberts JP, Lake JR. Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Hepatology. 1994 Jul; 20(1 Pt 1):105-10. View in PubMed
  225. Kuwatsuru R, Liu T, Cohen F, Shames DM, Osorio RW, Mann J, Rosenau W, Mühler A, Neuder MS, Roberts JP. Acute liver transplantation rejection. Early detection of endothelial leak in a rat model using magnetic resonance imaging and a macromolecular contrast medium. Invest Radiol. 1994 Jun; 29 Suppl 2:S297-9. View in PubMed
  226. Freise CE, Liu T, Hong K, Osorio RW, Papahadjopoulos D, Ferrell L, Ascher NL, Roberts JP. The increased efficacy and decreased nephrotoxicity of a cyclosporine liposome. Transplantation. 1994 Mar 27; 57(6):928-32. View in PubMed
  227. Chazouillères O, Mamish D, Kim M, Carey K, Ferrell L, Roberts JP, Ascher NL, Wright TL. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet. 1994 Jan 15; 343(8890):142-6. View in PubMed
  228. Osorio RW, Ascher NL, Jaenisch R, Freise CE, Roberts JP, Stock PG. Major histocompatibility complex class I deficiency prolongs islet allograft survival. Diabetes. 1993 Oct; 42(10):1520-7. View in PubMed
  229. Hebert MF, Roberts JP. Endstage liver disease associated with nitrofurantoin requiring liver transplantation. Ann Pharmacother. 1993 Oct; 27(10):1193-4. View in PubMed
  230. Bumgardner GL, Roberts JP. New immunosuppressive agents. Gastroenterol Clin North Am. 1993 Jun; 22(2):421-49. View in PubMed
  231. Ascher NL, Lake JR, Emond JC, Roberts JP. Liver transplantation for fulminant hepatic failure. Arch Surg. 1993 Jun; 128(6):677-82. View in PubMed
  232. LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, Roberts JP, Ascher NL. Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology. 1993 May; 187(2):413-20. View in PubMed
  233. Osorio RW, Freise CE, Stock PG, Lake JR, Laberge JM, Gordon RL, Ring EJ, Ascher NL, Roberts JP. Nonoperative management of biliary leaks after orthotopic liver transplantation. Transplantation. 1993 May; 55(5):1074-7. View in PubMed
  234. Martinez OM, Villanueva JC, Lake J, Roberts JP, Ascher NL, Krams SM. IL-2 and IL-5 gene expression in response to alloantigen in liver allograft recipients and in vitro. Transplantation. 1993 May; 55(5):1159-66. View in PubMed
  235. Martinez OM, Ascher NL, Ferrell L, Villanueva J, Lake J, Roberts JP, Krams SM. Evidence for a nonclassical pathway of graft rejection involving interleukin 5 and eosinophils. Transplantation. 1993 Apr; 55(4):909-18. View in PubMed
  236. Freise CE, Hebert M, Osorio RW, Nikolai B, Lake JR, Kauffman RS, Ascher NL, Roberts JP. Maintenance immunosuppression with prednisone and RS-61443 alone following liver transplantation. Transplant Proc. 1993 Apr; 25(2):1758-9. View in PubMed
  237. Krams SM, Martinez OM, Villanueva JC, Lake J, Roberts JP, Ascher NL. T-cell receptor-V alpha gene use in sequential liver allograft biopsies. Transplant Proc. 1993 Feb; 25(1 Pt 1):84-5. View in PubMed
  238. Stock PG, Ascher NL, Osorio RW, Tomlanovich S, Lake JR, Nikolai B, Freise C, Roberts JP. Standard sequential immunosuppression with Minnesota antilymphoblast globulin and cyclosporine vs FK 506: a comparison of early nephrotoxicity. Transplant Proc. 1993 Feb; 25(1 Pt 1):675-6. View in PubMed
  239. Martinez OM, Krams SM, Villanueva JC, Ferrell L, Lake J, Roberts JP, Ascher NL. Intragraft eosinophilia and interleukin-5 mRNA accompany liver allograft rejection. Transplant Proc. 1993 Feb; 25(1 Pt 1):126-7. View in PubMed
  240. Osorio RW, Freise CE, Ascher NL, Roberts JP, Avery M, Lake JR. Orthotopic liver transplantation for end-stage alcoholic liver disease. Transplant Proc. 1993 Feb; 25(1 Pt 2):1133-4. View in PubMed
  241. Osorio RW, Ascher NL, Jaenisch R, Natuzzi ES, Freise CE, Roberts JP, Stock PG. Isolation of functional MHC class I-deficient islet cells. Transplant Proc. 1993 Feb; 25(1 Pt 2):968-9. View in PubMed
  242. Ascher NL, Lake JR, Emond JC, Roberts JP. Liver transplantation at the University of California, San Francisco. Clin Transpl. 1993; 175-7. View in PubMed
  243. Hebert MF, Roberts JP, Prueksaritanont T, Benet LZ. Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction. Clin Pharmacol Ther. 1992 Nov; 52(5):453-7. View in PubMed
  244. LaBerge JM, Ring EJ, Lake JR, Ferrell LD, Doherty MM, Gordon RL, Roberts JP, Peltzer MY, Ascher NL. Transjugular intrahepatic portosystemic shunts: preliminary results in 25 patients. J Vasc Surg. 1992 Aug; 16(2):258-67. View in PubMed
  245. Lidofsky SD, Bass NM, Prager MC, Washington DE, Read AE, Wright TL, Ascher NL, Roberts JP, Scharschmidt BF, Lake JR. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology. 1992 Jul; 16(1):1-7. View in PubMed
  246. Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, Combs C, Fennessy S, Roberts JP, Ascher NL. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology. 1992 Jul; 103(1):317-22. View in PubMed
  247. Liu T, Freise CE, Ferrell L, Ascher NL, Roberts JP. A modified vascular "sleeve" anastomosis for rearterialization in orthotopic liver transplantation in rats. Transplantation. 1992 Jul; 54(1):179-80. View in PubMed
  248. Ring EJ, Lake JR, Roberts JP, Gordon RL, LaBerge JM, Read AE, Sterneck MR, Ascher NL. Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ann Intern Med. 1992 Feb 15; 116(4):304-9. View in PubMed
  249. Lake JR, Roberts JP, Ascher NL. Maintenance immunosuppression after liver transplantation. Semin Liver Dis. 1992 Feb; 12(1):73-9. View in PubMed
  250. Martinez OM, Krams SM, Sterneck M, Villanueva JC, Falco DA, Ferrell LD, Lake J, Roberts JP, Ascher NL. Intragraft cytokine profile during human liver allograft rejection. Transplantation. 1992 Feb; 53(2):449-56. View in PubMed
  251. Prager MC, Johnson KL, Ascher NL, Roberts JP. Anesthetic care of patients with Crigler-Najjar syndrome. Anesth Analg. 1992 Jan; 74(1):162-4. View in PubMed
  252. Krams SM, Falco DA, Villanueva JC, Rabkin J, Tomlanovich SJ, Vincenti F, Amend WJ, Melzer J, Garovoy MR, Roberts JP. Cytokine and T cell receptor gene expression at the site of allograft rejection. Transplantation. 1992 Jan; 53(1):151-6. View in PubMed
  253. Hebert MF, Ascher NL, Lake JR, Roberts JP. Efficacy and toxicity of FK 506 for the treatment of resistant rejection in liver transplant patients. Transplant Proc. 1991 Dec; 23(6):3109-10. View in PubMed
  254. Freise CE, Rowley H, Lake J, Hebert M, Ascher NL, Roberts JP. Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient. Transplant Proc. 1991 Dec; 23(6):3173-4. View in PubMed
  255. LaBerge JM, Ferrell LD, Ring EJ, Gordon RL, Lake JR, Roberts JP, Ascher NL. Histopathologic study of transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol. 1991 Nov; 2(4):549-56. View in PubMed
  256. Roberts JP, Ascher NL, Lake J, Capper J, Purohit S, Garovoy M, Lynch R, Ferrell L, Wright T. Graft vs. host disease after liver transplantation in humans: a report of four cases. Hepatology. 1991 Aug; 14(2):274-81. View in PubMed
  257. Freise CE, Clemmings S, Clemens LE, Alan T, Ashby T, Ashby E, Burke EC, Roberts JP, Ascher NL. Demonstration of local immunosuppression with methylprednisolone in the sponge matrix allograft model. Transplantation. 1991 Aug; 52(2):318-25. View in PubMed
  258. Wright TL, Hsu H, Donegan E, Feinstone S, Greenberg H, Read A, Ascher NL, Roberts JP, Lake JR. Hepatitis C virus not found in fulminant non-A, non-B hepatitis. Ann Intern Med. 1991 Jul 15; 115(2):111-2. View in PubMed
  259. Roberts JP, Ring E, Lake JR, Sterneck M, Ascher NL. Intrahepatic portocaval shunt for variceal hemorrhage prior to liver transplantation. Transplantation. 1991 Jul; 52(1):160-2. View in PubMed
  260. Aldape KD, Fox HS, Roberts JP, Ascher NL, Lake JR, Rowley HA. Cladosporium trichoides cerebral phaeohyphomycosis in a liver transplant recipient. Report of a case. Am J Clin Pathol. 1991 Apr; 95(4):499-502. View in PubMed
  261. Freise CE, Pons V, Lake J, Burke E, Ascher NL, Roberts JP. Comparison of three regimens for cytomegalovirus prophylaxis in 147 liver transplant recipients. Transplant Proc. 1991 Feb; 23(1 Pt 2):1498-500. View in PubMed
  262. Burke EC, Martinez OM, Freise CE, McVicar J, Roberts JP, Ascher NL. MHC expression on human hepatocytes before and after isolation. Transplant Proc. 1991 Feb; 23(1 Pt 2):1428-9. View in PubMed
  263. Freise CE, Hong K, Clemens LE, Papahadjopoulos D, Burke E, Martinez O, Lake J, Ascher NL, Roberts JP. Characterization of a cyclosporine-containing liposome. Transplant Proc. 1991 Feb; 23(1 Pt 1):473-4. View in PubMed
  264. Olcott EW, Ring EJ, Roberts JP, Ascher NL, Lake JR, Gordon RL. Percutaneous transhepatic portal vein angioplasty and stent placement after liver transplantation: early experience. J Vasc Interv Radiol. 1990 Nov; 1(1):17-22. View in PubMed
  265. Roberts JP, Hughes L, Goldstone J, Ascher NL. Examination of vascular anastomoses during liver transplantation by intraoperative Doppler duplex scanning. Clin Transplant. 1990 Aug; 4(4):206-9. View in PubMed
  266. Ostroff JW, Roberts JP, Gordon RL, Ring EJ, Ascher NL. The management of T tube leaks in orthotopic liver transplant recipients with endoscopically placed nasobiliary catheters. Transplantation. 1990 May; 49(5):922-4. View in PubMed
  267. Prager MC, Gregory GA, Ascher NL, Roberts JP. Massive venous air embolism during orthotopic liver transplantation. Anesthesiology. 1990 Jan; 72(1):198-200. View in PubMed
  268. Roberts JP, Debas HT. A simplified technique for rapid truncal vagotomy. Surg Gynecol Obstet. 1989 Jun; 168(6):539-41. View in PubMed
  269. Roberts JP, Shackford S, Peters RM. Metabolism of D lactate in patients receiving hypertonic sodium lactate solution. Surg Gynecol Obstet. 1989 May; 168(5):429-32. View in PubMed
  270. Roberts JP, Forsmark C, Lake JR, Ascher NL. Liver transplantation today. Annu Rev Med. 1989; 40:287-303. View in PubMed
Data provided by UCSF Profiles, powered by CTSI at UCSF. View profile of John P. Roberts, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.